GnuBio Obtains $5,000,000 New Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    64 Sidney St. Cambridge, MA 02139
  • Company Description
    GnuBIO is a genomics company developing next-generation sequencing technology for the molecular diagnostic and applied research markets. The GnuBIO system is based on emulsion and microfluidic technology developed at Harvard University.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing-amended.
  • M&A Terms
  • Venture Investor

Trending on Xconomy